Biopharmaceuticals Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Biopharmaceuticals stocks.


Compare ETFs

    Recent Signals

    Date Stock Signal Type
    2021-05-05 EPRSQ Crossed Above 20 DMA Bullish
    2021-05-05 EPRSQ Narrow Range Bar Range Contraction
    2021-05-05 EPRSQ MACD Bullish Signal Line Cross Bullish
    2021-05-05 EPRSQ Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
    2021-05-05 NONOF Fell Below 20 DMA Bearish
    2021-05-05 NONOF Volume Surge Other
    2021-05-05 NONOF MACD Bearish Signal Line Cross Bearish
    2021-05-05 PBIGF Hot IPO Pullback Bullish Swing Setup
    2021-05-05 PBIGF Narrow Range Bar Range Contraction
    2021-05-05 PHGUF Narrow Range Bar Range Contraction
    2021-05-05 PHMMF MACD Bearish Signal Line Cross Bearish
    2021-05-05 PHMMF Stochastic Reached Oversold Weakness
    2021-05-05 PVCT Bollinger Band Squeeze Range Contraction
    2021-05-05 PVCT 1,2,3 Retracement Bearish Bearish Swing Setup
    2021-05-05 PVCT Calm After Storm Range Contraction
    2021-05-05 PVCT 50 DMA Support Bullish
    2021-05-05 PVCT NR7 Range Contraction

    A biopharmaceutical, also known as a biologic(al) medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenics, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.
    Terminology surrounding biopharmaceuticals varies between groups and entities, with different terms referring to different subsets of therapeutics within the general biopharmaceutical category. Some regulatory agencies use the terms biological medicinal products or therapeutic biological product to refer specifically to engineered macromolecular products like protein- and nucleic acid-based drugs, distinguishing them from products like blood, blood components, or vaccines, which are usually extracted directly from a biological source. Specialty drugs, a recent classification of pharmaceuticals, are high-cost drugs that are often biologics. The European Medicines Agency uses the term advanced therapy medicinal products (ATMPs) for medicines for human use that are "based on genes, cells, or tissue engineering", including gene therapy medicines, somatic-cell therapy medicines, tissue-engineered medicines, and combinations thereof. Within EMA contexts, the term advanced therapies refers specifically to ATMPs, although that term is rather nonspecific outside those contexts.
    Gene-based and cellular biologics, for example, often are at the forefront of biomedical research, and may be used to treat a variety of medical conditions for which no other treatments are available.In some jurisdictions, biologics are regulated via different pathways than other small molecule drugs and medical devices.The term biopharmacology is sometimes used to describe the branch of pharmacology that studies biopharmaceuticals.

    More about Biopharmaceuticals
    Browse All Tags